Adenoid Cystic Carcinoma (ACC) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Adenoid Cystic Carcinoma (ACC) – Drugs In Development, 2024 report and make more profitable business decisions.
Adenoid cystic carcinoma (ACC) is a rare and aggressive type of cancer that originates from glandular tissues. It can occur in various parts of the body, but it is most found in the salivary glands of the head and neck region. ACC is characterized by a MYB oncogene activation and a tendency to invade nerves and metastasize to distant organs. The treatment options for ACC include surgery, radiotherapy, and chemotherapy, depending on the stage and location of the tumor. ACC has a high five-year survival rate, but it often recurs after many years and has a poor long-term prognosis.
The Adenoid Cystic Carcinoma (ACC) drugs in development market research report provide comprehensive information on the therapeutics under development for Adenoid Cystic Carcinoma (ACC), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Adenoid Cystic Carcinoma (ACC) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Adenoid Cystic Carcinoma (ACC) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 41 molecules, with 38 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Adenoid Cystic Carcinoma (ACC) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Adenoid Cystic Carcinoma (ACC) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Adenoid Cystic Carcinoma (ACC) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Actuate Therapeutics IncAlligator Bioscience AB
Anaveon AG
Ascentage Pharma Group International
Ayala Pharmaceuticals Inc.
Bayer AG
BeiGene Ltd
BioAtla Inc
Bristol-Myers Squibb Co
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Curevac NV
CytomX Therapeutics Inc
Eisai Co Ltd
Elevar Therapeutics Inc
Eli Lilly and Co
Gilead Sciences Inc
Gongwin Biopharm Holdings Co Ltd
HLB Life Science Co Ltd
Ideaya Biosciences Inc
Indaptus Therapeutics Inc
Innovent Biologics Inc
Jacobio Pharmaceuticals Group Co Ltd
Karus Therapeutics Ltd
Kronos Bio Inc
Merck & Co Inc
Novartis AG
OncoC4 Inc
Oxford BioTherapeutics Ltd
Peter MacCallum Cancer Centre
QBiotics Group Ltd
Radboud University
RemeGen Co Ltd
Remix Therapeutics Inc
Seagen Inc
Shanghai Junshi Biosciences Co Ltd
Shengke Pharmaceuticals (Jiangsu) Ltd
Shepherd Therapeutics Inc
Soricimed Biopharma Inc
University of Queensland
VM Discovery Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Adenoid Cystic Carcinoma (ACC) reports